|
1
|
Ohgaki H: Genetic pathways to
glioblastomas. Neuropathology. 25:1–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hou LC, Veeravagu A, Hsu AR and Tse VC:
Recurrent glioblastoma multiforme: A review of natural history and
management options. Neurosurg Focus. 20:E52006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: Plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tonn JC and Goldbrunner R: Mechanisms of
glioma cell invasion. Local Therapies for Glioma Present Status and
Future Developments. Springer; pp. 163–167. 2003, View Article : Google Scholar
|
|
5
|
Fu Z and Tindall DJ: FOXOs, cancer and
regulation of apoptosis. Oncogene. 27:2312–2319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu M, Lee D, Xia W, Xia W, Golfman LS,
Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, et al: IkappaB kinase
promotes tumourigenesis through inhibition of Forkhead
transcription factor FOXO3a. Cell. 117:225–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang J-Y, Chang C-J, Xia W, Wang Y, Wong
KK, Engelman JA, Du Y, Andreeff M, Hortobagyi GN and Hung MC:
Activation of FOXO3a is sufficient to reverse mitogen-activated
protein/extracellular signal-regulated kinase kinase inhibitor
chemoresistance in human cancer. Cancer Res. 70:4709–4718. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu
LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, et al:
Constitutively nuclear FOXO3a localization predicts poor survival
and promotes Akt phosphorylation in breast cancer. PLoS One.
5:e122932010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lam M, Carmichael AR and Griffiths HR: An
aqueous extract of Fagonia cretica induces DNA damage, cell cycle
arrest and apoptosis in breast cancer cells via FOXO3a and p53
expression. PLoS One. 7:e401522012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shukla S, Bhaskaran N, Maclennan GT and
Gupta S: Deregulation of FoxO3a accelerates prostate cancer
progression in TRAMP mice. Prostate. 73:1507–1517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shukla S, Bhaskaran N, Babcook MA, Fu P,
Maclennan GT and Gupta S: Apigenin inhibits prostate cancer
progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Carcinogenesis. 35:452–460. 2014. View Article : Google Scholar :
|
|
12
|
Chen Q, Ganapathy S, Singh KP, Shankar S
and Srivastava RK: Resveratrol induces growth arrest and apoptosis
through activation of FOXO transcription factors in prostate cancer
cells. PLoS One. 5:e152882010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sunayama J, Sato A, Matsuda K, Tachibana
K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K,
et al: FoxO3a functions as a key integrator of cellular signals
that control glioblastoma stem-like cell differentiation and
tumorigenicity. Stem Cells. 29:1327–1337. 2011.PubMed/NCBI
|
|
14
|
Wang W, Li N-N, Du Y, Lv F-F and Lin G-Q:
FoxO3a and nilotinib-induced erythroid differentiation of CML-BC
cells. Leuk Res. 37:1309–1314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruvolo PP: The Herculean task of killing
cancer cells: Suppression of FOXO3A in acute leukemia involves a
hydra of multiple survival kinases. Cell Cycle. 11:2589. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kops GJ, Medema RH, Glassford J, Essers
MA, Dijkers PF, Coffer PJ, Lam EW and Burgering BM: Control of cell
cycle exit and entry by protein kinase B-regulated forkhead
transcription factors. Mol Cell Biol. 22:2025–2036. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hauck L, Harms C, Grothe D, An J, Gertz K,
Kronenberg G, Dietz R, Endres M and von Harsdorf R: Critical role
for FoxO3a-dependent regulation of p21CIP1/WAF1 in response to
statin signaling in cardiac myocytes. Circ Res. 100:50–60. 2007.
View Article : Google Scholar
|
|
18
|
Miyauchi H, Minamino T, Tateno K, Kunieda
T, Toko H and Komuro I: Akt negatively regulates the in vitro
lifespan of human endothelial cells via a p53/p21-dependent
pathway. EMBO J. 23:212–220. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rathbone CR, Booth FW and Lees SJ: FoxO3a
preferentially induces p27Kip1 expression while impairing muscle
precursor cell-cycle progression. Muscle Nerve. 37:84–89. 2008.
View Article : Google Scholar
|
|
20
|
Roy SK, Chen Q, Fu J, Shankar S and
Srivastava RK: Resveratrol inhibits growth of orthotopic pancreatic
tumors through activation of FOXO transcription factors. PLoS One.
6:e251662011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Obexer P, Geiger K, Ambros PF, Meister B
and Ausserlechner MJ: FKHRL1-mediated expression of Noxa and Bim
induces apoptosis via the mitochondria in neuroblastoma cells. Cell
Death Differ. 14:534–547. 2007. View Article : Google Scholar
|
|
22
|
Storz P, Döppler H, Copland JA, Simpson KJ
and Toker A: FOXO3a promotes tumor cell invasion through the
induction of matrix metalloproteinases. Mol Cell Biol.
29:4906–4917. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tenbaum SP, Ordóñez-Morán P, Puig I,
Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert
JD, Mendizabal L, et al: β-catenin confers resistance to PI3K and
AKT inhibitors and subverts FOXO3a to promote metastasis in colon
cancer. Nat Med. 18:892–901. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Osuka S, Sampetrean O, Shimizu T, Saga I,
Onishi N, Sugihara E, Okubo J, Fujita S, Takano S, Matsumura A, et
al: IGF1 receptor signaling regulates adaptive radioprotection in
glioma stem cells. Stem Cells. 31:627–640. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang
HT and Li X: microRNA-155 regulates cell proliferation and invasion
by targeting FOXO3a in glioma. Oncol Rep. 30:2111–2118.
2013.PubMed/NCBI
|
|
26
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Troussard AA, Costello P, Yoganathan TN,
Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase
(ILK) induces an invasive phenotype via AP-1 transcription
factor-dependent upregulation of matrix metalloproteinase 9
(MMP-9). Oncogene. 19:5444–5452. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kupferman ME, Fini ME, Muller WJ, Weber R,
Cheng Y and Muschel RJ: Matrix metalloproteinase 9 promoter
activity is induced coincident with invasion during tumor
progression. Am J Pathol. 157:1777–1783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rao JS, Yamamoto M, Mohaman S, Gokaslan
ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL
and Sawaya RE: Expression and localization of 92 kDa type IV
collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp
Metastasis. 14:12–18. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao Y, Xiao A, diPierro CG, Carpenter JE,
Abdel-Fattah R, Redpath GT, Lopes MB and Hussaini IM: An extensive
invasive intracranial human glioblastoma xenograft model: Role of
high level matrix metalloproteinase 9. Am J Pathol. 176:3032–3049.
2010. View Article : Google Scholar : PubMed/NCBI
|
